Dehydration-induced AVP stimulates glucagon release and ketogenesis.
Hill TG. et al, (2025), Am J Physiol Endocrinol Metab
Nicotinic Signaling Stimulates Glucagon Secretion in Mouse and Human Pancreatic α-Cells.
Hamilton A. et al, (2025), Diabetes, 74, 53 - 64
Loss of electrical β-cell to δ-cell coupling underlies impaired hypoglycaemia-induced glucagon secretion in type-1 diabetes.
Hill TG. et al, (2024), Nat Metab
Author Correction: Every islet matters: improving the impact of human islet research
Gloyn AL. et al, (2024), Nature Metabolism
Electrophysiological characterisation of iPSC-derived human β-like cells and an SLC30A8 disease model.
Jaffredo M. et al, (2024), Diabetes
The endoplasmic reticulum plays a key role in α-cell intracellular Ca2+ dynamics and glucose-regulated glucagon secretion in mouse islets.
Acreman S. et al, (2024), iScience, 27
An unclear role for the GLP-1 metabolite GLP-1(9–36) in human islet physiology. Reply to Matveyenko A, Vella A [letter]
Gandasi NR. and Rorsman P., (2024), Diabetologia
GLP-1 metabolite GLP-1(9-36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion.
Gandasi NR. et al, (2023), Diabetologia
Glucose Controls Glucagon Secretion by Regulating Fatty Acid Oxidation in Pancreatic α-Cells.
Armour SL. et al, (2023), Diabetes, 72, 1446 - 1459
Platelet-derived lipids promote insulin secretion of pancreatic β cells.
Karwen T. et al, (2023), EMBO Mol Med
History of key regulatory peptide systems and perspectives for future research
Chen D. et al, (2023), Journal of Neuroendocrinology
Alpha-Cell Heterogeneity Contributes to Phasic Glucagon Release
Miranda CA. et al, (2023), DIABETES, 72
Electrophysiological characterisation of iPSC-derived human β-like cells and anSLC30A8disease model.
Jaffredo M. et al, (2023)
Optogenetic Control of Pancreatic Delta Cells Reveals Their Central Role in Hormone Release from Pancreatic Islets
Dou H. et al, (2023), DIABETES, 72
Physical interaction between beta and delta cells
Rorsman P., (2023), HORMONE RESEARCH IN PAEDIATRICS, 96, 13 - 14
Using a somatostatin receptor-2 antagonist to restore hypoglycaemia-induced glucagon secretion in type 1 diabetes
Hill TG. et al, (2023), DIABETOLOGIA, 66, S50 - S50
Altered glycolysis triggers impaired mitochondrial metabolism and mTORC1 activation in diabetic β-cells.
Haythorne E. et al, (2022), Nat Commun, 13
Every islet matters: improving the impact of human islet research
Gloyn AL. et al, (2022), Nature Metabolism